Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is ...

The compounding power of Moore's Law allowed for the internet the smartphone and AI. Now Ian says it's being applied to the ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

Tempus AI's diagnostics arm is surging in 2025 as precision oncology testing, MRD adoption, AI-driven genomic tools and the Ambry Genetics acquisition expand capabilities.

The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and strong market growth.

Rare diseases affect more people than cancer yet medicine looked the other way. Artificial intelligence is finally looking back ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor ...

By Rowland Illing, AWS Chief Medical Officer and Director of Global Healthcare and Nonprofits  It's one of medicine's tragic paradoxes that, collectively, ...

The growth of the companion diagnostics market is largely driven by the sharp worldwide rise in cancer incidence. Increasing awareness of precision medicine among patients, along with manufacturers' ...

DelveInsight's Companion Diagnostics Market Insights report provides the current and forecast market analysis, individual leading companion diagnostics companies' market shares, challenges, companion ...